TORONTO, August 4 – The CNIB Foundation, Canada's largest non-profit serving people with sight loss, has signed a new partnership agreement with IrisVision, global leader in digital vision technologies.
IrisVision’s visual assistive device allows users to access and amplify their limited sight. The wearable device is FDA registered, and helps users with a variety of eye conditions including age-related macular degeneration, Stargart disease, and glaucoma.
On Monday, Bill C-20 received Royal Assent. This legislation will provide a one-time, non-taxable and non-reportable payment of up to $600 to support Canadians with disabilities to assist with expenses incurred during the pandemic.
After extensive training, CNIB Guide Dogs is proud to announce the class of 2019. Twenty-five partnerships across Canada graduated today. Graduation ceremonies were held in St. John's, Ottawa, Toronto, Winnipeg and Vancouver.
CNIB's advocacy team is conducting research about the accessibility of insulin pumps for people who are living with diabetes and sight loss. As part of our research, we are launching a survey that will help us better understand the accessibility issues people face when administering insulin.